History

Prof. Marian Zembala

Professor Marian Zembala, M.D., Ph.D., cardiac surgeon, transplantologist, scientist. Graduated in 1974 with honors from the Faculty of Medicine of the Wroclaw Medical University. From 1975 to 1981 he was an assistant and senior assistant at the Department of Cardiac Surgery of this university. After receiving his doctorate in medical sciences, he became an assistant professor. He spent several years as a research intern in the Netherlands. In 1985 he took a job at the then established Department of Clinic of the Silesian Medical Academy in Zabrze (under the direction of Professor PhD., M.D. Zbigniew Religa). He then specialized in cardiac surgery.

In 1992 he was habilitated on the basis of a dissertation entitled Surgical myocardial reperfusion in fresh myocardial infarction. In 1993, he became Director of the Silesian Centre for Heart Diseases in Zabrze and served in this position until March 2022. In 1997, he became a member of the National Transplantation Council, and from 1997 to 1999 was President of the Polish Transplantation Society. In 1998, he received the title of professor of medical sciences. He rose to the position of full professor at the Medical University of Silesia and head of the Department of Cardiac Surgery and Transplantation. In 2018 he was awarded an honorary doctorate by the Wroclaw Medical University, and in 2021 he received the highest title of honorary professor by the Silesian Medical Academy, posthumously awarded the Order of the White Eagle by the President of Republic of Poland.

He was involved in heart and lung transplantation, in 1997 he was the first in Poland to perform a single lung transplantation, and was the creator of many pioneering developments in cardiac surgery and heart and lung transplantation. In 2011, he became chairman of the Scientific Council to the Minister of Health. From 2010 to 2012, he was president of the European Society of Cardiovascular and Endovascular Surgery, then president of the European Association for Cardio-Thoracic Surgery. The only Pole in history to have served as president of Both European Cardiac Surgery Societies. In 2015 he assumed the position of Minister of Health of the Republic of Poland.

Professor PhD., M.D. Marian Zembala was the originator and initiator of the establishment of the Silesian  Park of Medical Technology Kardio-Med Silesia. The project of creating and launching the Silesian  Park of Medical Technology Kardio-Med Silesia was implemented by Professor Marian Zembala together with the President of Zabrze – Mrs. Małgorzata Mańka-Szulik and the Silesian Medical Academy. On the organizational and management side, the Chairman & CEO of the Silesian  Park of Medical Technology Kardio-Med Silesia – Mr. Adam Konka – is responsible for the creation of this research and implementation infrastructure in 2013-2015 and for development and ongoing management.

Prof. Marek Radomski

Professor Marek Witold Radomski, M.D., Ph.D., currently, the vice-dean of research in College of Medicine at the University of Sasktchewan in Canada. Professor Radomski used to be the Chair of the Department of Pharmacology at Trinity College Dublin in Ireland. Professor Radomski graduated from the Jagiellonian University Medical College and obtained his M.D./Ph.D. in 1983. In 2002 he became Professor.

Professor Radomski is a long-time pharmacologist with years of experience in working both in academia and pharmaceutical industry in Poland (Jagiellonski University in Krakow and Polish Academy of Sciences in Warsaw), UK (Wellcome Research Laboratories in Beckenham), Spain (Lacer SA in Barcelona), Canada (University of Alberta in Edmonton) and USA (University of Texas in Houston. For the last 9 years, Professor Radomski has been the Professor of Pharmacology at Trinity College in Dublin. He has experience in academic teams management acquired in his own research team as well as the Centre for Cancer Research in the Department of Pharmacology at Trinity College Dublin. Professor Radomski has mentored more than 60 doctoral and post-doctoral graduates. He has also led research and development operations in pharmaceutical companies, such as Wellcome Research Laboratories (UK) and Lacer (Spain). He was Alberta Heritage Foundation for Medical Research scholar and scientist of the Canadian Institutes of Health Research. He has been appointed Doctor Honoris Causa by the Complutense University of Madrid and Fellow of Trinity College Dublin.

Professor Radomski also conducts audits of academic units in USA and Europe and has consulted pharmaceutical companies, such as Eli Lilly, Schwarz Pharma, Merck and Phytopharm. Currently, he is member of the Scientific and Medical Advisory Board at Solvotrin Therapeutics.

He is interested in platelet and vascular biology, pharmacological mediators including nitric oxide and matrix metalloproteinases, and most recently, in nanomedicine, nanopharmacology and nanotoxicology. Professor Radomski is a highly-cited pharmacologist (listed in www.isihighlycited.com, with more than 18,900 citations to date by Google Scholar).

From July 2013 to April 2016, Professor Marek Radomski was working in Kardio-Med Silesia as the Director for Science and Medicine. Currently, he is continuing his cooperation with Kardio-Med Silesia in research projects.